• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cvent Holding Corp. (Nasdaq - CVT), Absolute Software Corporation (Nasdaq – ABST), Home Point Capital, Inc. (Nasdaq – HMPT), Magenta Therapeutics, Inc. (Nasdaq –

By: Brodsky & Smith LLC via GlobeNewswire
May 11, 2023 at 09:54 AM EDT

BALA CYNWYD, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Cvent Holding Corp. (Nasdaq - CVT)

Under the terms of the agreement, Cvent will be acquired by an affiliate of private equity funds managed by Blackstone (“Blackstone”) in a transaction with an enterprise value of approximately $4.6 billion. Under the terms of the agreement, Cvent stockholders will receive $8.50 per share in cash for each share of the Company they own. The investigation concerns whether the Cvent Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Blackstone is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/cvent-holding-corp-nasdaq-cvt/ .

Absolute Software Corporation (Nasdaq – ABST)

Under the terms of the agreement, Absolute will be acquired by funds affiliated with Crosspoint Capital Partners, L.P. (“Crosspoint”). Absolute shareholders will receive $11.50 per Common Share in cash on completion of the Acquisition, corresponding to an enterprise value of approximately $870 million, inclusive of the debt. The investigation concerns whether the Absolute Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Crosspoint is paying too little for the Company. For example, the deal consideration is below the 52-week high of $12.59 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/absolute-software-corporation-nasdaq-abst/.

Home Point Capital, Inc. (Nasdaq – HMPT)

Under the terms of the Merger Agreement, Home Point will be acquired by Mr. Cooper Group Inc. (“Mr. Cooper”) (Nasdaq – COOP). Mr. Cooper will acquire all outstanding shares of Home Point for approximately $324 million. The investigation concerns whether the Home Point Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Mr. Cooper is paying too little for the Company.

Additional information can be found athttps://www.brodskysmith.com/cases/home-point-capital-inc-nasdaq-hmpt/ .

Magenta Therapeutics, Inc. (Nasdaq – MGTA)

Under the terms of the Merger Agreement, Magenta will merge with Dianthus Therapeutics, Inc. (“Dianthus”). Pre-merger Dianthus stockholders are expected to own approximately 78.7% of the combined company and pre-merger Magenta stockholders are expected to own approximately 21.3% of the combined company. Immediately prior to the closing of the proposed merger, Magenta stockholders will be issued contingent value rights representing the right to receive certain payments from proceeds received by the combined company, if any, related to pre-transaction legacy assets. The investigation concerns whether the Magenta Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company’s shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/magenta-therapeutics-inc-nasdaq-mgta/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

More News

View More
Golden Cross Alert: 3 Stocks With Serious Upside Potential
Today 17:34 EDT
Via MarketBeat
Tickers CSX DDOG GOOGL
Big Beat, Bigger Plans: AEP Stock Powers Up on Data Center Boom
Today 16:41 EDT
Via MarketBeat
Tickers AEP
UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale
Today 16:09 EDT
Via MarketBeat
Topics Economy
Tickers T UPS VZ WBA
Why Byrna Could Be the Top Defense Stock to Watch Now
Today 16:05 EDT
Via MarketBeat
Topics ETFs
Tickers AMZN BYRN SHLD
Why Bloom Energy Stock Could Break to New Highs
Today 14:02 EDT
Via MarketBeat
Tickers BE
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap